Generate:Biomedicines announced a publication in Nature describing Chroma, a generative AI model that can program novel proteins not previously found in nature with targeted biophysical,...
Dose-escalation study to evaluate ORB-011 as single agent, with initial safety, pharmacokinetic and mechanism-based pharmacodynamic readouts
Orionis Biosciences, a life sciences company pioneering the creation...
Charles River Laboratories International, Inc. and Aitia, a leader in the application of Causal AI and Digital Twins, announced a strategic agreement that gives Aitia...
Code Ocean, the world's first Reproducible Research Cloud, announced that it has been selected as a winner of the 2023 BioTech Breakthrough Awards in the...
VeriSIM Life announces recognition for continued advances with BIOiSIM, a first-in-class virtual drug development engine.
VeriSIM Life— the leading artificial intelligence (AI)-enabled, unique R&D decisions...
A global consortium of scientists from federal laboratories, research institutes, academia, and industry has formed to address the challenges of building large-scale artificial intelligence (AI) systems...
Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to industrialize drug discovery, announced that they have updated the focus...